GU
Knight Ther
GUD.TO·TSXMontreal CAFounded 2014200 employees
Small CappharmaPublicOncology
Platform: Canadian Spec
Market Cap
$0.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (GUD.TO)
Loading GUD.TO stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Darasotorasib | GUD-4539 | Preclinical | 1 | PCSK9 | ALS | ||
| Elrarapivir | GUD-2445 | Phase 2 | 2 | Nectin-4 | NB |
SEC Filings & Financial Documents
SEC filings are not available for TSX-listed companies.
Knight Ther trades on TSX (CA). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)